New York, NY, United States of America

David Muehsam

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Electro Cellular Healthcare Solutions LLC. Active years: 2024-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by David Muehsam in Electromagnetic Field Stimulation

Introduction

David Muehsam is an innovative inventor based in New York, NY (US). He has made significant contributions to the field of healthcare through his inventions focused on reducing inflammation. With a total of 3 patents, Muehsam's work is paving the way for advancements in medical technology.

Latest Patents

Muehsam's latest patents include methods and devices for using pulsed radiofrequency electromagnetic field stimulation to reduce inflammation. These inventions provide methods and devices aimed at reducing pro-inflammatory cytokine molecules while increasing anti-inflammatory signaling molecules in mammals. One of the devices comprises a power supply, an amplifier, an antenna, and a waveform generator. The signals produced can have an aperiodic continuous waveform function or an aperiodic pulse train that effectively reduces inflammation and enhances anti-inflammatory responses.

Career Highlights

David Muehsam is associated with Electro Cellular Healthcare Solutions LLC, where he continues to develop innovative solutions for healthcare challenges. His work is characterized by a commitment to improving health outcomes through technology.

Collaborations

Muehsam collaborates with notable professionals in his field, including Sean Hagberg and Norton Herrick. Their combined expertise contributes to the advancement of Muehsam's innovative projects.

Conclusion

David Muehsam's contributions to the field of electromagnetic field stimulation represent a significant step forward in medical technology. His inventions are set to make a lasting impact on how inflammation is treated in mammals.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…